CCNE1 and ovarian carcinoma: In terms of frequency, the cyclin E1 gene is one of the most commonly amplified genes in ovarian cancer (19%), anaplastic thyroid cancer (29%) and osteosarcoma (27-33%) (14, 17, 18, 29).